Literature DB >> 2404746

Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.

S Sandler1, K Bendtzen, D L Eizirik, M Welsh.   

Abstract

Recently it has been postulated that interleukin-1 (IL-1) locally released by infiltrating mononuclear cells may destroy the pancreatic B cells during the development of insulin-dependent diabetes mellitus. Since IL-1 is a potent inducer of interleukin-6 (IL-6) in various cells, it is conceivable that IL-6 is a second mediator of the IL-1 action. In the present study the effects of IL-6 alone or in combination with IL-1 were studied on pancreatic islet function in vitro after tissue culture and compared with the effects observed after exposure to IL-1 only. Rat pancreatic islets were cultured in medium RPMI 1640 + 10% calf serum with or without the addition of human recombinant IL-6 (500-5000 pg/ml) for 48 h. The medium insulin accumulation was increased by 40-50% after culture with 500-2000 pg/ml IL-6, but was similar to the controls at 5000 pg/ml. When islets were cultured for 18 h only, also 5000 pg/ml IL-6 stimulated the medium insulin accumulation. IL-6 did not affect the islet insulin content and the rates of islet (pro)insulin and total protein biosynthesis. It inconsistently decreased the islet DNA content. In short-term experiments after 48-h culture with IL-6, there was a dose-dependent inhibition of the glucose-stimulated insulin release. On the other hand, islets cultured with IL-6 (5000 pg/ml) exhibited an elevated glucose oxidation and oxygen uptake, but a lower ATP content at 16.7 mM glucose and an unaffected glucose utilization and glutamine oxidation compared to the controls. This raises the possibility that IL-6 had induced a condition with an increased energy expenditure, resulting in an enhanced mitochondrial metabolism of glucose. Islets cultured with human recombinant IL-1 beta (25 units/ml) showed a strong inhibition of the insulin accumulation in the culture medium and of glucose-stimulated insulin release and a marked decrease in the islet DNA and insulin content. A combination of IL-1 (25 U/ml) + IL-6 (1000 pg/ml) did not alter the inhibitory action of IL-1 alone. The present findings thus show that IL-6 induces a dissociation between insulin secretion and glucose oxidation in islets in vitro. This has not been observed in islets exposed to IL-1, which suggests that IL-6 does not solely mediate the inhibitory effects of IL-1 on islet function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404746     DOI: 10.1210/endo-126-2-1288

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

2.  Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.

Authors:  C Southern; D Schulster; I C Green
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

3.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Authors:  D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Coronary microvascular dysfunction in diabetes mellitus: A review.

Authors:  Andrea Picchi; Stefano Capobianco; Tianyi Qiu; Marta Focardi; Xiaoqin Zou; Ji-Min Cao; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

5.  RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db.

Authors:  Abraham Neelankal John; Ramesh Ram; Fang-Xu Jiang
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

6.  Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice.

Authors:  Rebecca E K MacPherson; Laura Castellani; Marie-Soleil Beaudoin; David C Wright
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

7.  Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation.

Authors:  A Rabinovitch; W L Suarez; P D Thomas; K Strynadka; I Simpson
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

8.  Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment.

Authors:  M Hill; R McCallum
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Role of interleukin-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients.

Authors:  Tetsuji Shinohara; Naohiko Takahashi; Kunio Yufu; Futoshi Anan; Tetsuya Kakuma; Masahide Hara; Mikiko Nakagawa; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-01       Impact factor: 9.236

10.  Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.

Authors:  E-ri M Sol; Tea Sundsten; Peter Bergsten
Journal:  Lipids Health Dis       Date:  2009-02-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.